No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
451 |
4. Check minimum number of eventsNone |
451 |
5. Include endpointsNone |
451 |
6. Filter based on genotype QC (FinnGen only) |
451 |
Control definitions (FinnGen only)
- Control exclude
- J10_INTERSTITIUM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF6
- Parent code in ICD-10
- J80-J84
- Name in latin
- Syndroma dyspnoicum adultorum
Similar endpoints
↥List of similar endpoints to
Adult respiratory distress syndrome
based on the number of shared cases.
Similar with more cases:
- Other respiratory diseases principally affecting the interstitium
- Condition for Implicit Sepsis (Organ dysfunction codes)
- Diseases of the respiratory system
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 4454 | 1675 | 2699 |
| Only index persons | 2675 | 1057 | 1618 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.07 | 0.05 | 0.08 |
| Only index persons | 0.05 | 0.04 | 0.06 |
| Median age at first event (years) | |||
| Whole population | 64.11 | 63.05 | 64.59 |
| Only index persons | 63.57 | 61.33 | 65.04 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 451 | 160 | 291 |
| Unadjusted period prevalence (%) | 0.10 | 0.05 | 0.13 |
| Median age at first event (years) | 62.35 | 54.23 | 66.81 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 408
- Matched controls
- 4078
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J80
ICD-10 Finland
Adult respiratory distress syndrome
+∞
323.0
386
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
7.3
74.2
248
710
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
6.1
49.8
165
410
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
7.3
41.8
111
199
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
+∞
33.8
32
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
6.7
33.4
92
169
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
+∞
28.5
27
*
WX872
NOMESCO Finland
Intensive care
7.7
27.3
66
99
5185A
ICD-9 Finland
Other diseases of lung, Pulmonary insufficiency following trauma and surgery
+∞
23.1
22
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
7.9
21.4
50
71
WX730
NOMESCO Finland
Conventional respirator
13.2
18.9
33
27
ZXD05
NOMESCO Finland
Urgent procedure
2.7
18.1
175
899
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.8
17.6
61
143
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.9
17.5
50
94
GBB00
NOMESCO Finland
Tracheostomy
13.4
17.4
30
24
TPH07
NOMESCO Finland
Cathetrisation of artery
4.0
17.4
75
218
C03CA01
ATC
furosemide; systemic
2.5
16.8
180
968
TK800
NOMESCO Finland
Hemodialysis
9.2
16.8
35
41
A41.9
ICD-10 Finland
Sepsis, unspecified
6.8
15.8
40
64
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
+∞
15.7
15
*
H02AB06
ATC
prednisolone; systemic
2.3
14.9
218
1350
J96.0
ICD-10 Finland
Acute respiratory failure
14.9
14.7
24
17
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.8
14.5
107
458
GD1AD
NOMESCO Finland
Thorax CT examination
6.0
13.7
38
69
J81
ICD-10 Finland
Pulmonary oedema
+∞
13.6
13
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.2
13.3
201
1238
J01MA12
ATC
levofloxacin; systemic
2.6
13.0
112
521
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.2
12.9
50
131
WX892
NOMESCO Finland
Monitored bed care
3.9
12.8
54
153
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
7.0
12.0
29
44
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
12.2
11.9
21
18
WX725
NOMESCO Finland
Noninvasive ventilation
5.4
11.8
35
69
TGC00
NOMESCO Finland
Bronchial lavation
7.3
11.5
27
39
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.2
11.1
61
210
A98
ICPC
Health maint/preventive medicine
0.5
10.9
253
3168
JN4BD
NOMESCO Finland
Extensive body CT
2.9
10.5
68
265
WX722
NOMESCO Finland
PEEP
4.1
10.1
39
102
I50.9
ICD-10 Finland
Heart failure, unspecified
2.4
10.0
92
436
J01MA14
ATC
moxifloxacin; systemic
3.1
9.7
54
189
Z3226
NOMESCO Finland
Physiotherapist
2.4
9.7
90
429
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.6
9.6
72
306
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.6
9.0
68
288
K65.0
ICD-10 Finland
Acute peritonitis
12.9
8.9
15
12
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
6.6
8.9
22
35
Z2446
NOMESCO Finland
Social worker
3.8
8.8
37
105
WX882
NOMESCO Finland
High dependency care
6.0
8.7
23
40
C07AB07
ATC
bisoprolol; oral
1.9
8.7
217
1540
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.9
8.6
53
199
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
20.5
8.5
12
6
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.0
8.4
26
55
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.2
8.2
43
146
A01AB10
ATC
natamycin; local oral
6.1
8.1
21
36
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
6.3
7.9
20
33
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
4.6
7.9
26
59
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.7
7.9
33
94
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
11.1
7.8
14
13
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.6
7.7
56
233
ZX120
NOMESCO Finland
Intravenous
2.8
7.6
51
201
L04AA06
ATC
mycophenolic acid; systemic
9.1
7.6
15
17
127
Kela drug reimbursment
Transplant complication
10.3
7.6
14
14
J96.1
ICD-10 Finland
Chronic respiratory failure
5.2
7.5
22
44
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
7.4
112
652
XG410
NOMESCO Finland
Flow-volume spirometry
4.0
7.4
28
73
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.8
7.3
30
84
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
9.6
7.3
14
15
B01AA03
ATC
warfarin; systemic
2.0
7.3
114
674
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.2
7.2
79
405
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.3
7.1
68
327
N05CF01
ATC
zopiclone; oral
1.8
7.1
142
914
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
4.8
7.0
22
48
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
6.9
95
531
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
5.0
6.9
21
44
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
14.1
6.9
11
8
R50.9
ICD-10 Finland
Fever, unspecified
2.2
6.9
72
361
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
11.2
6.8
12
11
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
5.8
6.8
18
32
R06.0
ICD-10 Finland
Dyspnoea
1.9
6.8
109
650
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
17.0
6.8
10
6
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
6.7
124
777
N05AA02
ATC
levomepromazine; systemic
3.8
6.7
27
75
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.7
6.6
45
179
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.4
6.5
22
52
N03AX16
ATC
pregabalin; oral
1.9
6.4
100
588
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.3
6.4
31
100
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.8
6.4
120
753
A02BC02
ATC
pantoprazole; systemic
1.7
6.4
249
1949
L04AX01
ATC
azathioprine; systemic
4.7
6.4
20
44
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
6.4
6.2
15
24
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
4.0
6.2
23
60
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
3.6
6.1
26
76
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
6.9
6.1
14
21
N17.8
ICD-10 Finland
Other acute renal failure
10.2
6.1
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
71
81
10.22
58.60
2.3
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
69
79
10.13
56.75
2.4
1.6
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
39
23
18.47
47.61
2.3
1.8
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
48
51
10.41
41.37
2.3
1.6
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
80
158
5.94
40.05
3.9
2.0
ug/l
1.2
1.9
0.52
75
140
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
51
62
9.15
39.73
2.2
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
43
44
10.70
38.00
2.0
1.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
44
48
10.05
37.13
2.0
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
43
46
10.23
36.80
2.1
1.6
—
—
—
0
0
(44806118)
34
33
11.06
31.04
2.4
1.5
—
—
—
0
0
(44790047)
34
33
11.06
31.04
2.4
1.5
—
—
—
0
0
(44790049)
34
33
11.06
31.04
2.4
1.5
—
—
—
0
0
(44790048)
34
33
11.06
31.04
2.4
1.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
35
38
9.90
29.52
2.2
1.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
35
41
9.17
27.87
2.2
1.7
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
141
554
3.25
27.43
7.5
3.5
mmol/l
0.8
0.8
1.30
134
518
(3003458) Phosphate [Moles/volume] in Serum or Plasma
121
438
3.41
26.86
14.8
6.0
mmol/l
1.1
1.0
1.10
115
406
(3019060) Gas panel - Arterial blood
81
230
4.07
25.71
17.0
6.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
57
123
5.16
25.53
5.8
2.4
u/ml
0.3
0.4
0.29
43
59
(3037692) Legionella sp identified in Specimen by Organism specific culture
20
11
18.98
24.86
1.8
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
35
51
7.36
23.24
2.9
2.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
55
125
4.87
23.13
3.7
3.3
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
102
369
3.28
22.32
21.2
9.9
%
93.3
95.7
2.03
97
359
(3003396) Base excess in Arterial blood by calculation
107
403
3.17
21.86
20.9
9.5
mmol/l
2.4
1.2
1.77
93
325
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
105
401
3.11
20.87
21.0
9.5
kpa
5.2
5.1
0.17
99
385
(3027801) Oxygen [Partial pressure] in Arterial blood
105
402
3.10
20.77
21.0
9.5
kpa
9.9
11.8
4.55
100
388
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
24
25
10.08
20.73
1.3
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
28
38
7.79
19.72
2.3
1.7
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
27
36
7.91
19.29
2.3
1.8
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
25
32
8.21
18.46
1.4
1.1
u/ml
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
23
27
8.92
18.16
2.0
1.6
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
30
49
6.49
17.88
1.3
1.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
190
1056
2.38
17.40
9.1
4.4
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
34
65
5.58
17.30
16.4
8.0
iu/ml
357.6
168.0
—
9
11
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
103
431
2.80
17.09
2.8
1.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
132
626
2.57
17.07
3.2
1.8
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
29
52
5.89
15.75
1.5
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
100
430
2.70
15.64
2.6
1.8
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
16
14
11.81
15.39
2.5
1.9
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
84
335
2.85
15.13
25.0
10.5
g/l
113.6
120.4
1.92
79
326
(1616796) Gas panel - Central venous blood
34
74
4.89
14.96
9.0
3.3
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
301
3713
0.43
14.79
53.6
22.8
g/l
125.9
135.6
16.06
295
3644
(3026361) Erythrocytes [#/volume] in Blood
301
3712
0.43
14.74
53.1
22.7
e12/l
4.2
4.5
12.54
294
3596
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
16
15
11.02
14.72
2.5
1.9
—
—
—
0
0
(3035941) MCH [Entitic mass]
301
3711
0.43
14.69
52.9
22.6
pg
30.2
30.4
1.21
296
3645
(3024731) MCV [Entitic volume]
301
3710
0.43
14.64
53.0
22.6
fl
91.8
91.4
0.62
296
3644
(3007461) Platelets [#/volume] in Blood
301
3708
0.43
14.54
53.7
22.7
e9/l
245.6
242.3
0.33
294
3603
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
70
258
3.03
14.51
2.2
1.6
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
302
3712
0.44
14.36
53.1
22.7
e9/l
8.2
6.8
8.46
294
3597
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
55
177
3.40
14.26
1.9
2.3
g/l
1.7
1.5
0.53
44
152
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
20
31
6.70
12.47
2.1
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
20
31
6.70
12.47
2.1
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
20
31
6.70
12.47
2.1
1.7
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
19
8.69
12.44
2.5
1.8
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
33
82
4.26
12.33
2.5
1.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
63
241
2.88
12.15
7.4
3.3
mmol/l
2.8
2.0
1.15
52
181
(3042936) Bacteria identified in Isolate by Culture
109
546
2.31
12.04
3.4
2.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
268
3384
0.49
11.95
5.1
5.0
mmol/l
2.6
2.7
1.07
243
3086
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
54
194
3.03
11.64
29.7
12.7
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
15
18
8.59
11.55
1.5
2.0
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
292
3571
0.48
11.53
20.2
10.6
u/l
29.7
26.4
1.81
281
3431
(40761511) CBC panel - Blood by Automated count
283
3491
0.49
11.28
37.2
14.6
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
81
374
2.42
10.67
1.5
1.3
titre
278.1
480.5
1.10
21
77
(3009343) pH of Capillary blood
63
260
2.65
10.48
8.3
3.2
ph
7.4
7.4
0.82
13
25
(3002032) Base excess in Venous blood by calculation
73
324
2.50
10.47
6.6
3.8
mmol/l
2.1
1.9
0.09
61
260
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
15
21
7.35
10.19
2.3
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
15
21
7.35
10.19
2.3
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
15
21
7.35
10.19
2.3
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
15
21
7.35
10.19
2.3
1.6
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
18
31
6.01
10.14
1.8
1.7
e9/l
1.0
1.0
0.06
12
14
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
88
434
2.28
9.94
5.9
4.0
u/l
310.8
237.0
2.97
81
409
(3021447) Carbon dioxide [Partial pressure] in Venous blood
72
325
2.45
9.94
6.7
3.8
kpa
6.0
5.8
0.74
67
315
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
266
3309
0.52
9.92
4.6
4.6
mmol/l
4.4
4.5
1.04
242
3039
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
254
3204
0.53
9.90
30.9
14.5
ml/min/173m2
77.6
77.9
0.06
217
2671
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
14
19
7.57
9.75
1.4
1.9
%
9.6
17.1
—
9
9
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
264
3285
0.53
9.70
4.6
4.5
mmol/l
1.4
1.4
1.16
241
2990
(46235355) HIV 1 and 2 tests - Meaningful Use set
87
433
2.25
9.59
2.1
1.7
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
28
76
3.86
9.31
4.0
2.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
23
54
4.43
9.23
3.0
3.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
33
101
3.45
9.22
2.7
1.6
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
175
1138
1.88
9.17
10.5
5.4
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
293
3516
0.52
9.17
46.5
18.3
mmol/l
138.9
139.7
4.56
288
3412
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
269
3309
0.54
9.09
5.1
4.7
mmol/l
6.4
6.0
2.40
241
2994
(3020630) Protein [Mass/volume] in Serum or Plasma
66
299
2.41
9.01
3.2
2.7
g/l
62.3
66.2
2.43
60
267
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
49
193
2.73
8.91
17.1
11.4
mmol/l
24.7
24.5
0.08
44
183
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
13
18
7.41
8.89
2.5
1.7
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
13
18
7.41
8.89
2.5
1.7
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
13
19
7.02
8.48
2.5
1.6
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
12
16
7.68
8.45
1.3
1.3
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
27
77
3.67
8.38
13.1
4.6
kpa
5.0
5.1
0.42
27
77
(3027315) Oxygen [Partial pressure] in Blood
27
77
3.67
8.38
12.9
4.5
kpa
8.0
8.3
0.49
27
77
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
24
64
3.90
8.18
2.2
1.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
26
74
3.67
8.09
4.0
2.3
%
14.6
15.4
0.38
16
37
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
11
14
8.03
8.02
2.5
6.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
22
57
4.01
7.79
2.2
1.5
u/ml
255.8
102.7
—
9
9
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
261
3191
0.57
7.71
4.7
4.1
mmol/l
1.5
1.3
3.18
240
2894
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
64
307
2.26
7.64
4.1
2.9
ng/l
284.1
200.2
0.44
59
276
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
258
3161
0.57
7.63
7.6
6.0
mmol/mol
42.1
40.5
1.32
234
2916
(3028626) Oxygen [Partial pressure] in Capillary blood
30
98
3.21
7.58
5.8
2.0
kpa
7.2
7.9
1.11
30
85
(3024139) IgG subclass 3 [Mass/volume] in Serum
14
26
5.53
7.29
1.1
1.2
g/l
0.2
0.3
—
8
19
(3027135) IgG subclass 1 [Mass/volume] in Serum
14
26
5.53
7.29
1.1
1.2
g/l
4.8
7.1
—
8
20
(3028192) IgG subclass 2 [Mass/volume] in Serum
14
26
5.53
7.29
1.1
1.2
g/l
2.9
2.4
—
8
20
(3012441) Differential panel - Pleural fluid
18
43
4.32
7.07
1.5
1.4
—
—
—
0
0
(3020891) Body temperature
33
119
2.91
7.06
10.4
4.1
—
—
—
0
0
(4062490)
14
27
5.32
7.01
1.1
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
79
1331
0.51
7.01
3.7
4.4
%
24.5
21.0
0.83
29
650
(3002179) Metamyelocytes/100 leukocytes in Blood
56
264
2.28
6.96
4.8
4.1
%
1.0
0.3
1.80
20
75
(3027945) Reticulocytes/100 erythrocytes in Blood
83
461
1.98
6.75
3.3
2.6
%
2.2
1.8
2.28
70
417
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
46
203
2.41
6.63
14.3
8.2
mmol/l
24.9
24.8
0.11
46
203
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
50
971
0.45
6.63
2.7
3.1
ug/l
0.6
0.8
1.41
32
648
(3000991) Gas panel - Venous blood
60
297
2.18
6.63
17.6
9.7
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
66
342
2.09
6.48
2.5
2.3
g/l
0.2
0.2
0.31
61
318
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
87
499
1.92
6.43
5.0
2.5
%
19.0
22.2
1.23
70
437
(3017181) Myelocytes/100 leukocytes in Blood
59
294
2.16
6.41
4.9
4.2
%
1.6
0.7
1.57
28
103
(3030905) Polymorphonuclear cells [#/volume] in Blood
20
57
3.63
6.23
3.4
2.6
e9/l
6.8
4.9
0.90
20
57
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
76
422
1.96
6.17
3.8
3.1
umol/l
5.1
8.0
2.76
66
377
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
10
8
12.75
6.11
1.2
1.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
159
1109
1.67
6.01
4.8
3.3
u/l
40.4
32.6
1.48
150
1051
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
208
1555
1.63
5.96
19.9
6.5
mmol/l
1.2
1.2
3.45
195
1392
(3006184) Hemoglobin [Mass/volume] in Capillary blood
23
75
3.18
5.85
3.0
2.0
g/l
121.6
127.4
0.37
18
57
(3004789) Transferrin [Mass/volume] in Serum or Plasma
89
530
1.85
5.83
4.9
2.4
g/l
2.1
2.3
1.53
83
490
(3042733) HLA Ab [Presence] in Serum
10
9
11.33
5.82
5.1
5.6
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
18
50
3.71
5.82
1.4
1.8
g/l
0.6
0.9
0.47
11
39
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
20
60
3.44
5.79
3.6
3.2
%
65.9
58.7
1.52
20
60
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
116
1668
0.59
5.59
3.8
5.2
ug/l
1.6
2.9
3.99
100
1481
(3007853) Bacteria identified in Skin by Aerobe culture
75
429
1.90
5.56
2.6
1.7
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
50
249
2.13
5.44
7.6
4.1
ng/l
146.5
88.1
2.41
44
222
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
292
3378
0.62
5.44
42.4
15.7
mg/l
36.8
25.9
4.35
269
2704
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
8
5
16.24
5.43
1.3
1.0
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
207
1572
1.59
5.40
12.2
5.9
%
8.0
8.8
3.09
199
1465
(3022948) Iron [Moles/volume] in Serum or Plasma
93
576
1.77
5.33
4.7
2.4
umol/l
10.2
12.6
3.04
87
534
(3002030) Lymphocytes/100 leukocytes in Blood
210
1604
1.58
5.32
11.7
5.7
%
21.0
26.6
8.96
200
1486
(1761868) Lipid panel - Serum or Plasma
71
1154
0.54
5.30
3.1
3.0
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
202
1531
1.58
5.28
11.6
5.6
%
0.5
0.6
2.64
192
1419
(3006504) Eosinophils/100 leukocytes in Blood
205
1567
1.57
5.11
11.7
5.6
%
2.5
2.9
1.54
196
1451
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
21
71
3.05
5.05
1.9
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
21
71
3.05
5.05
1.9
1.4
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
205
1571
1.56
5.03
12.0
5.5
%
63.8
58.0
7.35
195
1467
(3045788) Cell count panel - Pleural fluid
15
41
3.75
4.96
1.4
1.4
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
200
1530
1.55
4.92
10.7
4.8
g/l
31.0
35.2
13.17
187
1425
(4010399)
46
231
2.10
4.91
1.9
1.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
60
335
1.91
4.78
2.8
2.7
e9/l
80.7
69.4
1.16
46
262
(40760888) Immunoglobulin light chains.free panel - Serum
22
80
2.84
4.68
5.2
4.7
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
212
1658
1.53
4.63
9.8
5.4
e9/l
0.0
0.0
0.30
196
1423
(21494755) Public health laboratory ask at order entry panel
7
263
0.25
4.58
1.0
1.4
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
211
1653
1.52
4.55
9.8
5.4
e9/l
0.7
0.6
3.02
195
1408
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
8
8
10.15
4.53
11.5
11.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
19
65
3.01
4.49
1.6
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
141
1019
1.56
4.36
9.5
4.2
ph
7.4
7.4
0.06
29
181
(3011288) Drugs identified in Urine by Screen method
14
40
3.58
4.36
2.4
1.7
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
228
1829
1.50
4.31
11.9
6.5
umol/l
10.2
11.6
2.27
220
1740
(3004588) Protein electrophoresis panel - Serum or Plasma
47
250
1.98
4.31
3.1
2.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
39
195
2.09
4.22
9.9
3.3
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
18
62
2.98
4.22
1.7
1.2
u/ml
221.4
293.8
0.47
12
33
(3019198) Lymphocytes [#/volume] in Blood
213
1693
1.49
4.17
9.9
5.4
e9/l
1.7
2.0
0.85
198
1487
(3009542) Hematocrit [Volume Fraction] of Blood
256
2987
0.67
4.16
40.0
17.1
%
37.6
39.4
2.00
152
2072
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
109
750
1.60
4.14
3.2
1.7
mg/l
1.8
1.4
0.59
93
590
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
261
3033
0.67
4.14
4.7
4.3
mu/l
2.1
2.0
0.84
239
2707
(3013115) Eosinophils [#/volume] in Blood
215
1714
1.49
4.13
11.3
5.6
e9/l
0.2
0.2
0.04
200
1499
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
12
32
3.83
4.11
1.1
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
12
32
3.83
4.11
2.3
1.5
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
8
10
8.12
4.07
3.1
2.4
ug/l
72.9
125.4
—
8
10
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
213
1701
1.48
4.03
21.2
7.2
mmol/l
1.2
1.2
1.83
186
1432
(3035880) pH of Pleural fluid
11
28
4.00
4.00
1.9
1.1
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
14
43
3.33
3.94
1.4
1.3
e6/l
17116.0
29912.1
—
9
22
(3021440) Promyelocytes/100 leukocytes in Blood
49
273
1.89
3.94
5.2
4.4
%
0.1
0.1
0.09
25
94
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
62
373
1.77
3.90
2.4
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
24
101
2.45
3.88
1.7
1.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
23
95
2.50
3.87
1.5
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
103
710
1.58
3.87
2.1
1.8
nmol/l
1112.1
1171.7
0.30
77
542
(3014148) Varicella zoster virus Ab [Titer] in Serum
11
29
3.86
3.82
1.2
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
191
1508
1.46
3.75
15.3
9.6
inr
1.3
1.3
0.06
49
412
(3024471) HLA-A [Type]
8
12
6.76
3.68
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
8
12
6.76
3.68
1.0
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
13
40
3.32
3.65
2.2
2.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
46
258
1.87
3.63
5.3
4.3
%
0.0
0.1
0.66
20
81
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
18
68
2.72
3.60
1.5
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
55
328
1.77
3.57
2.5
1.6
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
6
6
10.11
3.50
2.5
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
14
47
3.04
3.44
1.7
1.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
9
253
0.34
3.42
2.4
1.7
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
12
37
3.30
3.36
2.8
4.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
11
32
3.50
3.35
1.5
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
20
83
2.48
3.35
2.0
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
14
48
2.98
3.33
2.0
1.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
234
2724
0.71
3.27
45.0
19.4
%
14.6
13.8
8.67
229
2671
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
6
7
8.67
3.27
1.3
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
19
78
2.50
3.26
5.0
3.1
—
—
—
0
0
(3004451) EKG impression Narrative
9
19
4.81
3.25
1.2
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
11
33
3.39
3.21
1.7
1.4
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
6
8
7.58
3.06
9.0
11.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
9
21
4.35
3.01
1.8
1.3
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
5
5
10.09
2.98
1.4
1.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
20
88
2.33
2.98
1.6
1.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
138
1063
1.43
2.96
2.9
2.1
u/l
341.4
217.2
0.37
132
995
(3013650) Neutrophils [#/volume] in Blood by Automated count
229
1928
1.38
2.91
16.8
9.2
e9/l
5.4
4.2
6.91
208
1674
(40760892) CBC W Ordered Manual Differential panel - Blood
96
692
1.49
2.90
6.9
4.8
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
27
137
2.03
2.86
1.4
2.2
u/l
44.7
37.8
0.44
21
120
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
10
31
3.28
2.79
1.4
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
17
74
2.35
2.61
1.8
1.4
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
11
38
2.94
2.60
1.8
2.8
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
15
62
2.47
2.56
2.2
1.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
119
914
1.41
2.56
2.8
2.2
mg/l
3.4
3.1
0.84
101
786
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
5
7
7.21
2.55
10.4
12.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
10
33
3.08
2.54
1.3
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
18
82
2.24
2.50
2.6
1.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
15
63
2.43
2.49
2.2
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
15
63
2.43
2.49
2.1
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
15
63
2.43
2.49
2.2
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
60
405
1.56
2.45
3.4
1.5
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
6
12
5.05
2.41
1.7
1.5
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
6
12
5.05
2.41
2.5
3.1
%
128.0
95.6
—
6
12
(3008536) Aspergillus sp Ab [Presence] in Serum
6
12
5.05
2.41
2.8
1.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
122
951
1.39
2.39
4.8
3.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
97
727
1.43
2.38
6.4
3.9
ng/l
870.6
266.0
0.50
82
591
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
8
6.30
2.37
1.2
1.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
56
375
1.56
2.37
6.2
3.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
156
1878
0.74
2.36
3.0
2.7
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
71
503
1.49
2.33
1.5
1.3
iu/ml
30.7
30.4
0.01
24
155
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
12
47
2.60
2.29
2.3
1.9
pg
31.3
33.4
0.63
12
47
(3044889) 12 lead EKG panel
211
2426
0.76
2.28
5.5
4.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
6
13
4.66
2.28
1.0
1.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
13
4.66
2.28
1.7
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
7
18
3.93
2.26
1.4
1.4
nmol/l
123.7
138.2
—
7
18
(3051651) Icteric interference index of Serum or Plasma
9
29
3.15
2.23
6.0
3.0
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
10
36
2.82
2.21
2.6
2.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
133
1626
0.74
2.19
7.6
5.0
estimate
0.0
0.0
0.00
32
303
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
6
165
0.36
2.19
2.2
1.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
19
94
2.07
2.19
1.6
1.5
ug/g
244.0
272.0
—
10
53
(3030467) Casts [#/volume] in Urine by Automated count
126
1001
1.36
2.18
4.8
3.3
e6/l
0.5
0.6
0.37
101
751
(3016879) Cocaine [Presence] in Urine
14
61
2.34
2.16
2.2
1.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
80
589
1.44
2.16
1.8
1.3
g/l
2.6
2.5
0.12
62
361
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
50
334
1.56
2.15
4.6
2.5
u/l
43.5
33.0
0.94
42
282
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
28
160
1.80
2.15
11.1
3.9
mmol/l
25.8
25.1
0.62
28
148
(3042111) Morphology [Interpretation] in Bone marrow Narrative
15
68
2.25
2.13
2.2
1.7
—
—
—
0
0
(3017704) Immunofixation for Urine
8
25
3.24
2.10
4.1
2.0
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
5
10
5.04
2.07
2.4
1.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
11
44
2.54
2.02
1.0
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
8
26
3.11
2.02
1.1
1.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
26
3.11
2.02
1.3
3.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
33
202
1.68
2.02
1.7
1.5
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
9
32
2.85
2.01
1.1
1.2
u/l
74.3
69.4
—
9
22
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
27
3.00
1.94
1.5
1.3
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
23
128
1.84
1.93
4.3
2.2
g/l
10.0
10.2
0.11
18
110
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
34
213
1.64
1.92
2.1
1.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
135
1104
1.32
1.90
5.0
3.3
e6/l
64.0
126.5
0.45
113
854
(3000850) Epithelial cells [#/volume] in Urine
96
748
1.36
1.87
3.8
2.5
e6/l
5.0
4.2
0.39
87
652
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
17
3.56
1.84
1.0
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
6
17
3.56
1.84
1.5
1.5
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
139
1146
1.31
1.84
3.9
3.2
ng/l
3070.8
1688.7
1.04
124
985
(3009261) Glucose [Presence] in Urine by Test strip
138
1646
0.77
1.83
5.8
3.7
estimate
0.0
0.0
0.00
29
285
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
7
23
3.07
1.80
2.3
1.9
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
11
47
2.37
1.79
2.1
1.4
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
23
133
1.77
1.73
4.3
2.2
g/l
3.3
3.2
0.15
17
103
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
194
2205
0.79
1.70
5.5
3.2
u/l
107.1
53.2
1.98
178
2050
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
142
1.73
1.68
4.2
2.1
g/l
3.6
3.7
0.25
17
101
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
142
1.73
1.68
4.2
2.1
g/l
7.5
7.5
0.01
17
106
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
142
1.73
1.68
4.2
2.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
29
446
0.63
1.66
1.4
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
8
31
2.61
1.66
1.0
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
28
174
1.65
1.65
2.0
1.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
11
49
2.28
1.65
2.1
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
11
49
2.28
1.65
2.1
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
11
49
2.28
1.65
2.1
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
11
49
2.28
1.65
2.1
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
11
50
2.23
1.58
2.1
1.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
219
2442
0.80
1.58
3.8
3.6
pmol/l
14.7
14.8
0.12
196
2166
(3026782) Osmolality of Urine
91
724
1.32
1.54
4.8
2.9
mosm/kgh2o
515.2
562.7
1.37
83
609
(3047007) Chlamydophila sp Ab [Presence] in Serum
8
33
2.45
1.54
1.1
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
16
86
1.89
1.52
1.6
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
11
51
2.19
1.51
4.4
3.7
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
47
336
1.45
1.51
2.8
2.5
ug/l
8.4
7.7
0.06
40
293
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
6
21
2.88
1.51
1.7
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
26
163
1.63
1.50
4.3
1.7
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
16
87
1.87
1.47
1.1
1.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
138
1611
0.79
1.47
5.5
3.7
estimate
0.0
0.0
0.00
34
294
(40758558) Short blood count panel - Blood
102
831
1.29
1.46
13.6
6.8
—
—
—
0
0
(4027681)
5
16
3.15
1.44
1.0
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
6
22
2.75
1.44
1.8
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
105
1263
0.78
1.43
5.7
3.8
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
16
88
1.85
1.43
1.4
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
16
88
1.85
1.43
1.1
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
16
89
1.83
1.39
2.5
1.6
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
39
274
1.46
1.38
3.9
2.9
ml/min/173m2
61.5
67.0
0.27
22
114
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
38
266
1.47
1.37
11.0
4.0
mmol/l
1.2
1.2
2.51
33
234
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
9
41
2.22
1.37
1.0
1.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
23
2.63
1.37
1.7
1.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
23
2.63
1.37
1.7
1.7
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
17
2.96
1.36
2.2
2.0
u/ml
1058.4
827.2
—
5
17
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
154
1329
1.24
1.36
3.2
2.2
nmol/l
74.6
77.2
0.53
137
1154
(3003181) Sodium [Moles/volume] in Urine
11
54
2.06
1.34
2.5
1.3
mmol/l
70.0
60.5
0.19
11
47
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
6
24
2.52
1.31
1.3
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
71
888
0.76
1.30
1.5
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
62
479
1.34
1.29
1.4
1.3
u/ml
20.5
6.1
0.71
21
180
(3018095) Leukocytes [#/volume] in Urine
146
1260
1.23
1.28
5.8
3.8
e6/l
187.2
108.9
0.43
120
909
(3051611) Lipemic interference index of Serum or Plasma
9
44
2.07
1.27
6.3
3.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
8
35
2.31
1.27
2.4
2.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
8
35
2.31
1.27
1.4
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
8
36
2.24
1.25
1.3
1.6
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
6
25
2.42
1.24
1.3
1.1
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
12
63
1.93
1.24
2.5
2.1
%
75.7
60.9
2.34
12
63
(3040151) Glucose [Moles/volume] in Capillary blood
10
49
2.06
1.23
3.9
8.8
mmol/l
7.3
6.8
—
10
41
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
26
2.32
1.19
1.2
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
6
26
2.32
1.19
1.0
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
10
50
2.02
1.17
1.2
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
13
72
1.83
1.16
1.2
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
12
65
1.87
1.14
1.1
1.1
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
8
40
2.02
1.12
1.3
1.3
nmol/l
0.5
0.5
—
8
34
(4281824)
7
31
2.28
1.11
1.0
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
92
767
1.25
1.10
1.7
1.7
pmol/l
552.5
6289744.8
0.50
73
636
(3035320) C reactive protein [Mass/volume] in Body fluid
5
21
2.40
1.09
2.6
1.9
—
—
—
0
0
(3016750) Collection duration of Urine
5
21
2.40
1.09
1.8
2.9
min
350.0
490.3
—
5
14
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
21
2.40
1.09
2.0
1.3
—
—
—
0
0
(4035726)
40
298
1.38
1.07
1.5
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
8
148
0.53
1.05
1.8
1.8
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
225
2057
1.19
1.04
16.5
5.1
mmol/l
7.4
6.8
3.58
217
1923
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
7
34
2.08
1.03
1.3
1.3
nmol/l
—
—
—
0
0
(3000492) Spirometry study
39
293
1.36
1.00
2.2
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
129
1127
1.20
0.98
5.2
2.6
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
0
30
0.00
0.97
0.0
1.2
—
3.3
—
0
12
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
7
37
1.91
0.94
1.3
1.3
—
—
—
0
0
(4306422)
7
37
1.91
0.94
1.1
1.1
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
146
1295
1.19
0.94
5.2
3.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
6
27
2.24
0.93
1.2
1.3
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
6
28
2.16
0.92
1.5
1.5
u/l
29.8
31.0
—
6
23
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
46
361
1.31
0.90
2.2
1.8
%
2.1
1.6
1.39
39
317
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
14
87
1.63
0.88
1.1
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
10
56
1.80
0.88
10.0
3.1
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
6
31
1.95
0.84
1.7
1.2
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
10
57
1.77
0.84
1.6
1.1
u/l
189.4
36.1
—
10
48
(3026008) Bacteria identified in Urine by Culture
114
1001
1.19
0.82
4.7
3.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
36
277
1.33
0.82
6.0
3.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
115
1011
1.18
0.82
4.2
3.2
mg/l
1756.1
290.2
0.94
75
669
(3015377) Calcium [Moles/volume] in Serum or Plasma
132
1175
1.17
0.81
5.9
3.4
mmol/l
2.3
2.3
2.78
119
1019
(3016650) Hepatitis A virus Ab [Presence] in Serum
10
58
1.74
0.80
1.1
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
24
325
0.72
0.79
1.4
1.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
7
122
0.57
0.79
2.6
1.6
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
0
26
0.00
0.78
0.0
1.1
—
1.1
—
0
12
(1617658) Protocol used for examination of sentinel lymph nodes
0
27
0.00
0.77
0.0
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
21
149
1.43
0.77
3.5
1.6
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
6
34
1.77
0.76
1.2
1.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
0
28
0.00
0.76
0.0
1.1
—
0.1
—
0
5
(3003888) Timothy IgE Ab [Units/volume] in Serum
0
28
0.00
0.76
0.0
1.1
—
5.9
—
0
12
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
9
53
1.71
0.76
1.3
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
9
53
1.71
0.76
1.1
1.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
10
160
0.62
0.75
1.3
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
9
54
1.68
0.75
1.4
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
13
84
1.56
0.72
1.5
1.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
73
623
1.20
0.72
4.1
3.0
e6/l
1.6
1.0
0.44
47
370
(3009508) Creatinine [Moles/volume] in Urine
118
1051
1.17
0.72
3.6
3.1
mmol/l
6.8
7.8
1.66
100
855
(3023410) Appearance of Cerebral spinal fluid
5
26
1.93
0.71
1.2
1.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
220
2347
0.88
0.69
6.6
4.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
121
1344
0.86
0.69
2.4
2.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
7
42
1.68
0.68
1.6
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
28
1.79
0.66
2.4
2.1
%
10.2
11.2
—
5
28
(3014271) Vancomycin [Susceptibility]
5
29
1.73
0.64
3.8
2.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
79
900
0.85
0.62
2.0
1.7
mmol/l
1.5
1.4
0.71
69
753
(3011397) Hemoglobin [Presence] in Urine by Test strip
64
742
0.84
0.62
5.0
3.7
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
237
2505
0.89
0.62
6.5
3.8
mm/h
22.0
13.1
7.35
227
2275
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
53
1.52
0.58
1.3
1.1
—
—
—
0
0
(3013512) EKG study
98
1092
0.87
0.58
5.3
4.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
36
1.68
0.57
1.2
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
80
903
0.86
0.57
5.1
3.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
22
168
1.33
0.56
1.5
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
18
135
1.35
0.52
1.2
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
15
202
0.73
0.51
4.3
4.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
79
883
0.87
0.49
5.4
3.8
estimate
0.0
0.0
0.50
30
285
(3001122) Ferritin [Mass/volume] in Serum or Plasma
152
1412
1.12
0.49
5.4
2.7
ug/l
324.6
143.1
2.01
142
1283
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
68
602
1.15
0.47
4.8
3.2
e6/l
1.8
1.7
0.08
42
354
(1761482) Bacteria [#/volume] in Urine by Culture
8
119
0.67
0.46
4.8
5.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
71
635
1.14
0.43
1.2
1.2
u/ml
1.0
1.0
0.02
20
174
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
31
1.62
0.43
1.2
1.1
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
5
32
1.57
0.42
1.0
1.7
mosm/kgh2o
261.2
281.0
—
5
22
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
32
1.57
0.42
1.0
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
8
60
1.34
0.40
1.4
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
36
420
0.84
0.40
15.2
7.1
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
2.4
—
71.9
—
0
12
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
28
333
0.83
0.39
1.3
1.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
20
245
0.81
0.37
3.9
2.8
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
9
71
1.27
0.36
2.2
1.2
—
2.5
—
0
10
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
12
90
1.34
0.36
1.4
1.3
—
—
—
0
0
(3019225) pH of Specimen
39
339
1.16
0.36
7.8
4.4
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
6
42
1.43
0.35
9.2
2.7
%
66.5
57.8
—
6
31
(1002224) Polysomnography panel
9
124
0.72
0.35
1.0
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
16
200
0.79
0.35
1.7
1.7
—
—
—
0
0
(3008898) HLA-B27 [Presence]
13
100
1.31
0.34
1.2
1.1
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
6
46
1.31
0.33
1.3
2.9
—
32.0
—
0
9
(3027456) Digoxin [Moles/volume] in Serum or Plasma
10
74
1.36
0.32
2.9
2.9
nmol/l
0.8
0.9
—
10
59
(40768797) Stomach Pathology biopsy report
50
452
1.12
0.28
1.4
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
39
348
1.13
0.27
2.2
2.2
ug/g
165.5
131.8
0.36
31
274
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
18
214
0.83
0.26
1.4
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
14
171
0.81
0.26
1.2
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
100
940
1.08
0.26
6.5
2.7
umol/l
3985.5
7505.5
0.41
82
804
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
21
180
1.17
0.24
1.2
1.2
iu/ml
18.6
144.6
—
6
73
(3017732) Neutrophils [#/volume] in Blood
25
218
1.16
0.24
3.4
2.4
e9/l
4.6
3.8
0.50
20
163
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
27
237
1.15
0.23
1.7
1.6
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
5
38
1.32
0.23
1.4
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
41
1.22
0.22
1.0
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
19
220
0.86
0.22
1.7
1.8
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
10
0.00
0.21
0.0
4.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
4.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
56
520
1.09
0.20
29.6
26.6
inr
2.0
1.3
—
6
69
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
48
1.25
0.20
2.0
1.6
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
6
48
1.25
0.20
1.8
1.3
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
6
48
1.25
0.20
1.5
1.6
ug/l
13.9
15.7
—
6
48
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
113
1082
1.06
0.18
4.6
3.9
mg/mmol
35.3
9.9
1.29
78
698
(3049717) Cytology report of Urine Cyto stain
16
185
0.86
0.18
3.2
2.9
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
92
876
1.06
0.18
1.9
1.6
nmol/l
18.2
20.5
0.94
85
725
(3002256) Pathology report gross observation
41
444
0.92
0.18
1.3
1.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
60
1.17
0.18
5.0
2.8
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
90
857
1.06
0.17
5.2
2.6
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
9
107
0.84
0.13
1.2
1.5
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
20
183
1.10
0.10
1.1
1.4
—
47.5
—
0
15
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
142
1451
0.97
0.09
2.5
2.0
pmol/l
93.9
93.5
0.04
92
769
(4034850)
12
107
1.12
0.08
21.3
9.9
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
19
175
1.09
0.08
2.7
2.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
66
681
0.96
0.07
3.3
3.1
mmol/l
2.5
2.4
1.35
56
594
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
12
108
1.11
0.07
1.3
1.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
82
0.85
0.07
1.4
1.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
7
85
0.82
0.07
1.1
1.8
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
9
100
0.90
0.06
2.3
1.7
nmol/l
25.8
41.5
—
9
94
(3037121) Protein [Mass/volume] in Urine
14
130
1.08
0.04
3.4
3.0
g/l
1.1
0.3
—
7
47
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
22
209
1.06
0.04
2.0
2.5
—
17.4
—
0
10
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
15
140
1.07
0.04
1.2
1.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
29
280
1.04
0.03
4.6
3.5
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
144
1426
1.01
0.03
6.0
3.9
ng/l
53.6
47.5
0.20
121
1041
(3052851) Hemolysis interference index of Serum or Plasma
12
113
1.06
0.02
7.1
3.3
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
265
2660
0.99
0.01
15.3
7.5
u/l
91.1
79.2
3.26
256
2473
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
40
392
1.02
0.01
2.7
4.3
ug/l
5.4
40.6
1.04
35
324
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
161
1602
1.01
0.01
7.5
4.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
69
696
0.99
0.00
5.4
4.0
kg/l
1.0
1.0
0.41
12
104
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
12
116
1.04
0.00
1.3
1.7
mg/l
4.4
3.1
0.32
12
85
(3022145) Colonoscopy Study observation
37
375
0.99
0.00
1.5
1.3
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
21
213
0.99
0.00
4.4
2.7
e6/l
0.2
0.3
0.11
21
208
(36660697) Celiac disease serology panel - Serum
22
218
1.01
0.00
1.2
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
149
1487
1.00
0.00
21.9
9.5
e9/l
0.0
0.0
0.37
127
1206
(40768793) Breast Pathology biopsy report
7
72
0.97
0.00
1.3
1.3
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
6
64
0.94
0.00
1.0
3.9
u/ml
3623.5
452.0
—
6
59
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
9
90
1.00
0.00
1.4
1.3
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.7
—
86.0
—
0
7
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
17.6
—
0
8
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
6
64
0.94
0.00
1.2
1.5
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
22.9
—
0
7
(3002619) Bacteria identified in Specimen by Culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
7
70
1.00
0.00
2.3
1.9
pmol/l
206.9
226.2
—
7
64
(3036071) Salmonella sp Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint J10_ARDS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| J10_ARDS | 4.114 [2.99, 5.67] | < 0.001 |
| Birth year | 0.993 [0.98, 1.0] | 0.123 |
During the follow-up period (1.1.1998 — 31.12.2019), 380 out of 840 females with J10_ARDS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| J10_ARDS | 3.869 [3.11, 4.82] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.02 |
During the follow-up period (1.1.1998 — 31.12.2019), 581 out of 1115 males with J10_ARDS died.
Mortality risk
Mortality risk for people of age
years, who have J10_ARDS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.343% | 0.847% |
| 5 | 2.574% | 4.935% |
| 10 | 6.118% | 11.15% |
| 15 | 11.445% | 19.998% |
| 20 | 18.726% | 31.948% |
Relationships between endpoints
↥Index endpoint: J10_ARDS – Adult respiratory distress syndrome
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data